Drug intelligence / Profile preview

Calm Active

Development stage: Unknown
Lead developer: Nutrinat

Overview

Calm Active is a dietary supplement formulated as a synergistic blend of amino acids, including GABA, L-Glycine, and L-Taurine, as well as cofactor nutrients like magnesium and B vitamins. It is designed to support normal neurological function, relaxation, and help reduce symptoms related to stress, irritability, and nervousness. The product is intended to promote calmness and may be used for general stress management[4][10].

Brand names: Calm Active
Other names: Calm Active

Targets

GABRR (GABA-A receptor subunit rho)Glycine receptor

Beyond the preview

Go deeper on Calm Active.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calm Active.

Explore the full profile